Navigation Links
Graves' disease: Quality of life and occupational disability
Date:5/8/2009

One in 2 patients with Graves' disease suffers impairments to their everyday lives. In the current edition of Deutsches rzteblatt International, Katharina Ponto and coauthors, from Mainz University, describe affected patients' psychological stresses and occupational disability (Dtsch Arztebl Int 2009; 106(17): 283-9).

Between 2006 and 2008, they surveyed 250 patients about their attitudes to life, occupational problems, and impairments to their everyday lives. Additionally, 400 physicians in private practice were asked to report on the extent and type of occupational disability. 36% of affected persons were written off sick, 5% even had to take early retirement, and 21% sought psychotherapeutic help. Among the doctors, 34% treated patients with fully impaired earning capacity.

Graves' disease is the most severe manifestation of autoimmune thyroid disease. Patients complain of dry eyes (loss of corneal moisture), proptosis, and diplopia. In severe cases, the optic nerve may be compressed and acuity of vision impaired. In most cases, affected patients can be cured or their disease stabilized. The authors therefore make a plea for early prevention and speedy rehabilitation. The study shows that in spite of modern therapeutic modalities, the disease is accompanied by seriously impaired quality of life.


'/>"/>

Contact: Elke Bartholomus
bartholomaeus@aerzteblatt.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Graves & Thyroid Disease National Patient Conference Set for San Diego, CA
2. Wreaths Decorate Veterans Graves Nationwide
3. NBTY Acquisition of Julian Graves Referred to U.K. Competition Commission
4. Drug May Be Dangerous for Kids With Graves Disease
5. Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference
6. Spirit of the Heart: Preventing Cardiovascular Disease: A Community Call to Action
7. Genomics of Cardiovascular Disease: Current Clinical Applications
8. Diagnostic Center for Disease: Robotic Prostatectomy - A Race to Failure?
9. Husband Seeks Votes for Alzheimers Disease: Early Detection Matters Project
10. Media coverage affects how people perceive threat of disease: study
11. Jett Travolta and Kawasaki Disease: Separating Fact From Fiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: